Ingredion (NYSE:INGR) reported record full-year 2025 results on Tuesday, underscoring the resilience of its high-margin specialty ingredients despite operational headwinds in North America.
Atkore (NYSE:ATKR) reported first-quarter fiscal 2026 results on Tuesday, February 3, 2026, revealing a sharp decline in profitability as the company navigates a challenging "pricing normalization" cycle in its core electrical conduit business.
Archer Daniels Midland (NYSE:ADM) reported fourth-quarter and full-year 2025 results on Tuesday that reflected a challenging cyclical downturn for the global grain giant.
Ball Corporation (NYSE:BALL) reported fourth-quarter and full-year 2025 results on Tuesday that showcased record cash flow and a massive shareholder return program, even as the company navigated the final phase of its post-aerospace-divestiture restructuring.
Massimo Group (NASDAQ:MAMO) announced on Tuesday that it has entered into a non-binding letter of intent to acquire 100% of FST Development Company, a move that signals the powersports manufacturer’s aggressive pivot toward AI-driven hardware and digital health robotics.
Vertex Pharmaceuticals (NASDAQ:VRTX) and WuXi Biologics announced a major license and research service agreement on Monday, February 2, 2026, aimed at developing an innovative trispecific T-cell Engager (TCE) for B-cell mediated autoimmune diseases.
Leiden, Netherlands-based Pharming Group (NASDAQ:PHARM) provided 2026 financial guidance and detailed its rare disease pipeline at its Investor Day on February 3, 2026.
Boeing (NYSE:BA) and Air Cambodia announced the airline's first-ever purchase of Boeing aircraft on Tuesday, unveiling a deal for up to 20 737-8 jets at the 2026 Singapore Airshow.
The U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to the supplemental Biologics License Application (sBLA) for DATROWAY® (datopotamab deruxtecan), a TROP2-directed antibody-drug conjugate (ADC).
Ares Management (NYSE:ARES) announced Tuesday that it has completed its acquisition of London-based BlueCove, a leader in scientific fixed-income management.
AudioCodes (NASDAQ:AUDC) reported fourth-quarter and full-year 2025 results on Tuesday that highlighted a steady transition toward high-margin software and artificial intelligence services.
Chunghwa Telecom (NYSE:CHT) reported fourth-quarter and full-year 2025 results on Tuesday that marked its highest annual earnings in eight years, fueled by a surge in digital transformation and 5G migration.
